prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |review

The formation of amyloid plaques may rely on the APOE є4 gene.  Therefore, drugs that affect the levels of ApoE protein in the brain may prevent the formation of fibrils, inhibit deposits or promote the removal of amyloid. 

This process may result in slowing or delaying the development of AD symptoms.

Researchers at the University of Washington at Seattle showed that having the APOE є4 allele impacted age at on-set of the disease by as much as 17 years (Warwick Daw et al. 2000).